Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

Clinical trial NCT00411073 · COMPLETED

Trial details

NCT number: NCT00411073
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2006-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.